Market Access Impact: Asthma/COPD (US) 2017

NEW YORK, Nov. 6, 2017 /PRNewswire/ --Two brands enjoy big market share boosts as market barriers hinder competitorsMarket barriers affect more than a third of asthma/COPD prescriptions in the US. According to our survey, roughly 55% of doctors can't prescribe certain brands because...